Veracyte (VCYT) Capital Expenditures Growth (1y) (2013 - 2026)
Veracyte (VCYT) Capital Expenditures Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 53.06% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 8.47% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 144.93% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -33.33% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 31.13% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -27.73% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 33.33% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 16.40% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 68.93% |
| 10 | Veracyte | 3.62 Bn | 3.32 Bn | 108.55 Mn | 122.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 122.32% |
| Mar 31, 2026 | 62.84% |
| Dec 31, 2025 | -8.72% |
| Sep 30, 2025 | 24.53% |
| Jun 30, 2025 | -53.57% |
| Mar 31, 2025 | -14.76% |
| Dec 31, 2024 | 65.84% |
| Sep 30, 2024 | -19.99% |
| Jun 30, 2024 | -8.82% |
| Mar 31, 2024 | 31.40% |
| Dec 31, 2023 | 33.39% |
| Sep 30, 2023 | 63.48% |
| Jun 30, 2023 | 21.04% |
| Mar 31, 2023 | -33.80% |
| Dec 31, 2022 | 122.59% |
| Sep 30, 2022 | -5.41% |
| Jun 30, 2022 | 64.37% |
| Mar 31, 2022 | 105.10% |
| Dec 31, 2021 | -5.29% |
| Sep 30, 2021 | 185.35% |